RXRX Operating Expenses

Recursion Pharmaceuticals Inc Clas · Operating Expenses

RXRX logo

RXRX Operating Expenses

Latest reported$518.41M
RXRX Operating Expenses ($64.15M → $518.41M)
High-resolution chart · PNG

RXRX operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Recursion Pharmaceuticals Inc Clas Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
601,859,000
492,605,000
351,349,000
237,133,000
192,775,000
88,028,000
64,152,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.